IDEXX Laboratories, Inc. (IDXX)

Market Cap	41.54B
Revenue (ttm)	3.93B
Net Income (ttm)	894.97M
Shares Out	80.42M
EPS (ttm)	10.82
PE Ratio	47.68
Forward PE	41.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	384,787
Open	507.03
Previous Close	501.57
Day's Range	505.81 - 517.80
52-Week Range	356.14 - 530.60
Beta	1.52
Analysts	Buy
Price Target	536.00 (+3.78%)
Earnings Date	May 1, 2025

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 21, 1991
• Employees: 11,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IDXX
• Website: https://www.idexx.com

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Analyst Forecast

According to 8 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $536.0, which is an increase of 3.78% from the latest price.

Price Target

$536.0

(3.78% upside)

Analyst Consensus: Buy